The lancet. Gastroenterology & hepatologyHumansCrohn DiseaseAntibodiesMonoclonalHumanized
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study.
Geert R D'Haens, Mark Löwenberg, Filip Baert, Peter Bossuyt, Tamás Molnár, Frank Hoentjen, Esmé Clasquin, Krisztina B Gecse, Melanie S Hulshoff, Gert De Hertogh, Matthias Lenfant, Lotte Oldenburg, Séverine Vermeire
Published: 202610.1016/S2468-1253(25)00233-X
Abstract
BACKGROUND: Vedolizumab is efficacious in inducing and maintaining clinical remission in Crohn's disease. However, prospective data about its efficacy in early Crohn's disease are scarce. We aimed to evaluate the ability of vedolizumab to promote cli…
Preview only. Read the full abstract at the source